Related Experiment Video
Updated: May 2, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
Acute-on-chronic liver failure: a new clinical entity
Richard Moreau1, Vicente Arroyo2
1Inserm U1149, Centre de Recherche sur l'Inflammation, Paris, France; Unité Mixte de Recherche (UMR) S1149, Université Paris Diderot-Paris 7, Paris, France; Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France; European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium, Hospital Clinic, Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas, Barcelona, Spain.
Acute-on-chronic liver failure (ACLF) is a distinct clinical entity in patients hospitalized with cirrhosis and organ failure, characterized by high mortality. Defining ACLF is crucial for understanding and managing this severe liver complication.
Area of Science:
- Hepatology
- Internal Medicine
- Critical Care Medicine
Background:
- Patients hospitalized for cirrhosis complications with organ failure face high short-term mortality risks.
- Acute-on-chronic liver failure (ACLF) describes this high-risk patient group.
- Previously, an evidence-based definition for ACLF was lacking.
Purpose of the Study:
- To establish diagnostic criteria for ACLF.
- To describe the natural history of ACLF.
- To differentiate ACLF from traditional decompensated cirrhosis.
Main Methods:
- Prospective observational European study (Chronic Liver Failure Consortium Acute-on-Chronic Liver Failure in Cirrhosis study).
- Inclusion of hospitalized patients with cirrhosis and acute complications.
- Analysis of diagnostic criteria, patient characteristics, and outcomes.
Main Results:
- ACLF is a distinct clinical entity with unique characteristics including younger age, alcoholic etiology, and higher systemic inflammation.
- Precipitating events include bacterial infections and active alcoholism.
- ACLF occurs in 31% of hospitalized cirrhosis patients with acute complications and is a leading cause of death.
Conclusions:
- ACLF is a newly defined clinical entity with a high mortality rate.
- It is distinct from decompensated cirrhosis and requires specific management strategies.
- Further research is needed to define subcategories of ACLF, such as severe sepsis and alcoholic hepatitis.
More Related Videos
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Acute Pancreatitis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

